Dr. Mahasti Amouei

Nuclear medicine specialist

 

Professional Experience1996 – Present: Shahid Beheshti University of Medical Sciences, Shohada-e-Tajrish Hospital, Tehran, Iran
Position: Head of Ward
Key Contributions: Established the Nuclear Medicine Department (including SPECT).

2005 – Present: Milad Hospital, affiliated with Iran’s Social Security OrganizationInstruction and learning.1995 – Tehran Medical University, Tehran, Iran
Iranian Board Certification in Nuclear Medicine
Required for any academic university position

1992 – 1995 – Tehran Medical University, Tehran, Iran
Residency in Nuclear Medicine

1984 – 1992 – Tehran Medical University, Tehran, Iran
Doctor of Medicine (General Physician)
Ranked 3rd in National ExaminationOverview of QualificationsThe 3rd International Congress and the 15th Iranian Congress of Nuclear MedicineScientific SecretaryMay 19–21, 2011, Tehran, Iran

International training course on imaging in ischemic heart disease (IHD) and cardiac failure for advanced users.Individual taking part27 November to 1 December 2010, International Atomic Energy Agency (IAEA), Tehran, Iran

National workshop on the development of new radiopharmaceuticals for diagnostic and therapeutic applicationsIndividual taking partJune 16, 2010
Atomic Energy Organization of Iran, Tehran, Iran

National Workshop on Sentinel Node LocalizationExecutive Board CommitteeNational Workshop on Sentinel Node Localization

Executive Committee, 2008, Iranian Society of Nuclear Medicine, Tehran, Iran

Continuing Medical Education by the Iranian Society of Nuclear Medicine (held monthly)

Scientific Secretary (held bimonthly)

From May 2009 to January 2011, Iranian Society of Nuclear Medicine, Tehran, Iran

National Workshop on Quality Control in Nuclear MedicineExecutive BoardIn 2007, Shahid Beheshti Medical University in Tehran, Iran, hosted an international training course on radiation protection and safety in nuclear medicine.Individual taking part5–10 March 2005, International Atomic Energy Agency (IAEA), Riyadh, Saudi Arabia

International Training Course in Nuclear CardiologyIndividual taking partJune 13, 2003 – International Atomic Energy Agency (IAEA), Tehran, IranResearch Publications1. Amoui M, Pirayesh E, Akhlaghpoor Sh, et al. Correlation Between CT/MRI and Bremsstrahlung SPECT of 32P Following Radioembolization of Hepatic Tumors. IJR. 7(1): 1-5, 2010.

2. Mirbagheri A, Sadegi A, Amouie M. Pyloric Injection of Botulinum Toxin for the Treatment of Refractory GERD Accompanied by Gastroparesis. Dig. Dis. Sci. 2008.

3. Tabeie F, Neshandar Asli E, Aghamiri SM, Amouei M, et al. Absorbed Doses in Staff and Patients Resulting from Diagnostic Nuclear Medicine Procedures. Iranian J. Radiat. Res. 2: 25-31, 2004.

4. Radioprotective Effect of Vitamin E on Bone Marrow Suppression Induced by P-32. Pajoohandeh, 19: 2002.

5. Multifocal Tuberculous Osteomyelitis: Findings on Bone Scan. Iranian Journal of Nuclear Medicine; 36: 2000.A book has been published.Neonatal Disorders and Nuclear Medicine in: Guideline of Neonatal Diseases, published by the Iranian Society of Perinatology, 2008.

Procedure Guidelines in Nuclear Medicine, published by Tabib Publisher, 2001.